La perfusion isolée de pelvis dans les récidives pelviennes non opérables en zone irradiées: résultats et essai en cours

Translated title of the contribution: Isolated pelvic perfusion in irradiated unresectable recurrence of pelvic tumor: Preliminary outcome and ongoing study

C. Uzan, D. Goere, F. Dumont, S. Gouy, J. Muret, A. Hakime, T. De Baere, S. Bonvalot

    Research output: Contribution to journalShort surveypeer-review

    5 Citations (Scopus)

    Abstract

    The technique of isolated pelvic perfusion (IPP) using extracorporal circulation is capable of delivering high dose chemotherapy in the pelvic cavity. This technique has improved over time, notably with the use of a G-suit placed and inflated above the iliac bifurcation to impede flow through percutaneous vascular routes. This approach is of potential value in patients with previously irradiated, locally advanced recurrences of cancer originating from the gynecological or gastro-intestinal organs. Administration of tumor necrosis factor alpha (TNF-α) in combination with melphalan seems to provide response rates similar to those obtained in the technique of isolated extremity perfusion. A preliminary Phase I study has shown promising results in terms of feasibility and response rates. A randomized study is currently underway to compare IPP to standard treatment in patients with unresectable recurrent pelvic tumors of gynecological or gastro-intestinal origin.

    Translated title of the contributionIsolated pelvic perfusion in irradiated unresectable recurrence of pelvic tumor: Preliminary outcome and ongoing study
    Original languageFrench
    Pages (from-to)S11-S16
    JournalJournal de Chirurgie Viscerale
    Volume151
    Issue numberSUPPL. 1
    DOIs
    Publication statusPublished - 1 Jan 2014

    Cite this